Due to the numerous causes for dry eye, a comprehensive dry eye evaluation is necessary to determine the root of the problem.  At Matossian Eye Associates, we offer the latest advancements in diagnostic equipment.  Just like fingerprints, no two eyes are the same.  This is why specialized advanced testing is necessary to determine the best treatment regimen to end your dry eye struggles.

Diagnosing Dry Eye Disease

Dry eyes can be diagnosed through a comprehensive eye examination and specialized testing. Your dry eye exam may include:

  • Dry Eye Questionnaire – This questionnaire will help determine the severity of your dry eye by calculating a OSDI (ocular surface diseast index) score.  You can download a PDF of this questionnaire by clicking here, or download the OSDI Dry Eye Questionnaire app available on Apple and Android devices by clicking here.
  • SPEED Questionnaire – This is another questionnaire commonly used to determine the severity of dry eye symptoms. SPEED stands for Standard Patient Evaluation of Eye Dryness. Click here to download this questionnaire.
  • Patient history to determine any symptoms the patient is experiencing and the presence of any general health problems, medications taken, or environmental factors that may be contributing to the dry eye problem.
  • External Examination of the Eye including lid structure and blink dynamics.
  • Evaluation of the Eyelids and Cornea using bright light and magnification.
  • Measurement of the Quantity and Quality of Tears for any abnormalities. Special dyes may be instilled in the eyes to better observe tear flow and to highlight any changes to the outer surface of the eye caused by insufficient tears.
  • Tear Osmolarity Testing for Dry Eye Disease is the only available objective test to determine the severity of Dry Eye Disease. This test measures the concentration of your tears. Matossian Eye Associates is pleased to announce that we have been certified as one of only a few practices in the tri-state area as an accredited dry eye center of excellence by Tear Lab Corporation. We are licensed to perform tear osmolarity testing.We take a tiny sample of tears from each eye and measure the osmolarity or concentration of the tears. The collection is painless and the analysis takes a few seconds. Once your Doctor has a measurement, s/he can design a personalized treatment plan specifically for you.
  • LipiView with Dynamic Meibomian Gland Imaging (DMI) – LipiView® is the first device of its kind that captures images of the meibomian glands inside your eyelids. Your physician will be able to determine whether you have Meibomian Gland Dysfunction (MGD) by reviewing the images. You will be able to see pictures of your own glands as black and white piano keys. With your physician’s explanation, you will be able to understand whether you have Meibomian Gland Disease. The purpose of the Meibomian Glands is to produce oil to lubricate the surface of your eye. If your glands are plugged-up and obstructed, the natural oils cannot flow to coat your ocular surface, leading to faster evaporation of your tears. This condition lead to evaporative dry eyes over time. LipiView ® can also asses your blinking function by analyzing your blink pattern. Incomplete or partial blinking results in a poor quality tear film, which worsens dry eye
  • MMP-9 testing with InflammaDry is a cutting-edge rapid diagnostic test that is used in conjunction with other traditional modalities to help our physicians accurately identify and treat inflammatory dry eye disease.
  • Sjögren’s Syndrome Test – Sjögren’s Syndrome is one of the early hallmarks of dry eye disease, giving our physicians a unique opportunity to diagnose this disease in its very early stages.Sjögren’s Syndrome is among the most common and under-diagnosed autoimmune diseases.  It affects approximately 4 million people in the US, of which 3 million are undiagnosed.  Currently, there is an average delay of 4.7 years for patients to receive an accurate diagnosis, and patients are often diagnosed in late stages of the disease after gland degradation has taken effect. Earlier detection is important to allow time for proper management.  MEA hopes to enhance the lives of the 1 in 10 estimated Dry Eye Patients who may actually be suffering from Sjögren’s Syndrome

Cynthia Matossian, MD Talks About the Results She is Getting Clinically from InfammaDry MMP-9 Test